Oncogenic pathways, inflammatory signaling, and epigenetic mechanisms influence the regulation of CTLA-4 expression and PD-L1 at the Ribonucleic Acid (RNA) level, fostering a version of immunity in cancer [47]. The gene discussed is CTLA4; the disease is cancer.